OpenAI acquires Orchestra Bio to fold drug-development agents into Rosalind
OpenAI said it acquired drug-development software startup Orchestra Bio, adding its team and technology to its life sciences AI model Rosalind and Rosalind Workbench to build agents that help pharma teams coordinate drug development.
Read the full story at OpenAI News ↗
Timeline · 11 reports
- 2026-10-21 14:47 · AI Insider
OpenAI Adds Locked Chats to ChatGPT and Acquires Orchestra Bio to Strengthen Life Sciences AI - 2026-10-21 08:32 · The Decoder
OpenAI acquires Orchestra Bio to build AI agents that speed up drug development - 2026-10-21 04:44 · Mint AI
ChatGPT adds locked chats feature with PIN and Face ID: How to protect private conversations - 2026-10-21 03:32 · r/artificial
OpenAI acquires Orchestra Bio, folds drug-development agents into Rosalind - 2026-10-20 23:40 · SiliconANGLE AI
OpenAI acquires Orchestra Bio to bring AI agents into drug development - 2026-10-20 20:35 · TechCrunch AI
OpenAI acquires startup Orchestra Bio to beef up its biotech business - 2026-10-20 18:24 · r/ArtificialInteligence
OpenAI acquires Orchestra Bio to connect research AI with drug-development operations - 2026-10-20 18:24 · r/OpenAI
OpenAI acquires Orchestra Bio to connect research AI with drug-development operations - 2026-10-20 18:10 · AlphaSignal
OpenAI Buys Orchestra Bio to Push Rosalind Into Drug Development Operations - 2026-10-20 17:55 · Axios AI+
Exclusive: OpenAI has acquired Orchestra Bio - 2026-10-20 00:00 · OpenAI News
OpenAI acquires Orchestra Bio